Lungs News and Research

RSS
EU provides €3 million to support research on chronic lung disease

EU provides €3 million to support research on chronic lung disease

Pitt investigators to lead $15 million federal initiative to manage breathing disorder clinical trials

Pitt investigators to lead $15 million federal initiative to manage breathing disorder clinical trials

Living 'green' walls may affect health of office workers

Living 'green' walls may affect health of office workers

Researchers discover new way to stop cancer cells from spreading

Researchers discover new way to stop cancer cells from spreading

Primary care doctors ill-prepared to cope with rising demand for cancer care in high-income countries

Primary care doctors ill-prepared to cope with rising demand for cancer care in high-income countries

Seno completes PIONEER Pivotal Study of non-invasive Imagio breast imaging system

Seno completes PIONEER Pivotal Study of non-invasive Imagio breast imaging system

LDCT lung cancer screening does not lead to unnecessary treatment

LDCT lung cancer screening does not lead to unnecessary treatment

Patients with advanced lung cancer receive more than recommended number of radiation therapy

Patients with advanced lung cancer receive more than recommended number of radiation therapy

Orlando Health gets Overall 3 Star Rating for bypass surgery and lobectomy

Orlando Health gets Overall 3 Star Rating for bypass surgery and lobectomy

New study identifies inflammatory lung disease as risk factor for insulin resistance, diabetes

New study identifies inflammatory lung disease as risk factor for insulin resistance, diabetes

Study raises hope for reducing life-threatening respiratory problems in infants

Study raises hope for reducing life-threatening respiratory problems in infants

Reducing tumor burden in lung cancer patients with advanced adenocarcinoma

Reducing tumor burden in lung cancer patients with advanced adenocarcinoma

GIOTRIF shows superior survival compared to Tarceva for patients previously treated with advanced squamous cell lung carcinoma

GIOTRIF shows superior survival compared to Tarceva for patients previously treated with advanced squamous cell lung carcinoma

Spiolto Respimat shown to be superior first line therapy over LABA/ICS for COPD

Spiolto Respimat shown to be superior first line therapy over LABA/ICS for COPD

New report implicates five genetic regions that play major roles in CF disease severity

New report implicates five genetic regions that play major roles in CF disease severity

Clinical trial shows nivolumab drug improves overall survival, quality of life in lung cancer patients

Clinical trial shows nivolumab drug improves overall survival, quality of life in lung cancer patients

Duke Medicine scientists use transparent fish to show how Cryptococcal meningitis takes over the brain

Duke Medicine scientists use transparent fish to show how Cryptococcal meningitis takes over the brain

Breakthrough research to be presented at AAO-HNSF 2015 Annual Meeting & OTO EXPO

Breakthrough research to be presented at AAO-HNSF 2015 Annual Meeting & OTO EXPO

Phase II IMvigor 210 data shows atezolizumab may prevent progression of metastatic urothelial bladder cancer

Phase II IMvigor 210 data shows atezolizumab may prevent progression of metastatic urothelial bladder cancer

European survey sheds light on decision-making criteria of physicians treating advanced lung cancer patients

European survey sheds light on decision-making criteria of physicians treating advanced lung cancer patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.